Trader notes, earnings previews, Confluences, weekly digests and roundups — long-form analysis grounded in ORTEX short interest, options flow and analyst data.
All articles — 32540 total
Healthpeak Properties reports Q2 results on August 4 with options traders taking a sharply more bullish stance than at any point in recent memory — a striking contrast to a stock that has barely budged in a week. The…
BR reports fiscal Q4 results on August 4 with options positioning at its most bullish in months — a notable contrast to cautious sentiment that dominated much of the summer. The clearest positioning signal is in…
Leidos Holdings reports Q2 results on August 4 against a backdrop of persistent analyst pessimism, rising short interest, and a stock that has quietly recovered 12% over the past month — setting up a genuine test of…
Duke Energy heads into its August 4 Q2 print with a notable reversal in short positioning since the last preview — and a less tidy analyst picture than it appeared ten days ago. The most important development since the…
TDG reports fiscal Q4 results on August 4 with a split analyst community, a chairman selling into strength, and options positioning that has turned distinctly more defensive over the past two weeks. The most…
Analyst consensus shifted upward for biopharma names and lower for materials and chemicals on August 1. Regeneron Pharmaceuticals saw its average analyst target price nudge up to $832.43. The $73.8 billion biotech…
Energy Transfer LP heads into its August 4 earnings report having gained 6.5% over the past month — outpacing almost every close midstream peer — while options traders remain conspicuously unbothered by the event. The…
FIS reports second-quarter results on August 4 with short sellers having spent the past two weeks quietly reducing their bets against the stock — a meaningful shift in the setup heading into a print that previously…
AIZ heads into its August 4 Q2 earnings report with the analyst community notably more optimistic than it was three months ago — and the stock trading close to where the freshly raised price targets say it should…
NRG Energy reports Q2 results on August 4 with options traders running their most bullish positioning in the past year — a sharp contrast to the stock's recent weakness. The clearest setup signal is in the options…
Waters Corporation heads into its August 4 earnings report with options traders showing an unusually strong appetite for downside protection. The clearest signal is in the put/call ratio, which has climbed to 2.06 —…
Sysco heads into its August 4 fiscal Q1 earnings report with short interest quietly rebuilding and the acquisition debate far from settled. The positioning story has shifted since the July 28 Q4 print. Short interest,…
SNN heads into its August 4 results with the lending market for its shares as tight as it has been all year. The borrow story dominates the setup. Availability has collapsed to just 1.5% — meaning for every 100 shares…
Rockwell Automation reports fiscal Q3 results on August 4 with options traders markedly more cautious than they have been at any point in recent months — a sharp contrast to borrow conditions that remain entirely…
Public Service Enterprise Group arrives at its August 4 earnings date having given back the recovery that defined the prior preview — the stock has slipped to $76.68, erasing the $79.81 bounce noted a week ago and now…
Prudential Financial reports Q2 results on August 4 with its stock now trading meaningfully above where the analyst community thinks it belongs — a gap that has only grown since the last note published here ten days…
PGR heads into its August 4 earnings print with a cluster of insider sales and the most defensive options positioning of the past year pulling in the same direction. The sharpest pre-earnings signal is the exodus of…
Pfizer heads into its August 4 earnings event carrying an unusual distinction: short sellers rebuilt aggressively after the July 28 beat, and that positioning has barely softened in the days since. Short interest tells…
Revvity arrives at its August 4 Q2 print with short pressure continuing to ease — but the stock's muted recovery and a divided analyst community mean the debate is far from settled. The bear retreat has extended since…
Merck & Co. heads into Tuesday's Q2 earnings call with the Street's bullish revision cycle still running, short sellers largely gone, and peers under pressure — leaving the stock to stand on its fundamentals alone. The…
